Founder Directory
Built by Keitoto
Founders7
Known for these resultsRole43%Role is parsed from founder titles in yc.db. Known for 43% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School86%School is matched from bios, case-sensitive for acronyms. 86% of these rows have at least one match.
- Axel Peytavin@ax_peyFounder/CEO · InnateF24Consumer · San Francisco
- Vignesh AnandFounder/CTO · InnateF24Consumer · San Francisco
- Kevin BuiFounder · Selera MedicalW24Healthcare · San Francisco
- Stacie ArechavalaFounder · Selera MedicalW24Healthcare · San Francisco
- Jasper Edgar NeggersFounder · Promakhos TherapeuticsS21Healthcare · Boston
- Katerina ChatziFounder · Promakhos TherapeuticsS21Healthcare · Boston
- Will MitchellFounder/CEO · RabbetS17Real Estate and Construction · Denver
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Axel PeytavinInnateFounder/CEOFall 2024ConsumerSan Francisco, United States7https://x.com/ax_peyVignesh AnandInnateFounder/CTOFall 2024ConsumerSan Francisco, United States7—Kevin BuiSelera MedicalFounderWinter 2024HealthcareSan Francisco, United States2—Stacie ArechavalaSelera MedicalFounderWinter 2024HealthcareSan Francisco, United States2—Jasper Edgar NeggersPromakhos TherapeuticsFounderSummer 2021HealthcareBoston, United States2—Katerina ChatziPromakhos TherapeuticsFounderSummer 2021HealthcareBoston, United States2—Will MitchellRabbetFounder/CEOSummer 2017Real Estate and ConstructionDenver, United States23—
Showing 1–7 of 7 founders
Jasper Edgar Neggers
Founder·Promakhos Therapeutics
PRIMARY INFO
RoleFounder· not in title
Team size2
BatchSummer 2021
LocationBoston, United States
Company statusActive
StageEarly
BIO
CSO and co-founder of Promakhos. In high school, Jasper built a web-shop. He obtained a BSc, MSc and PhD in Biomedical Sciences from KU Leuven. He pioneered the use of XPO1 inhibitors for treating cancer and invented a CRISPR-directed evolution technology for drug target deconvolution. Jasper then joined the Dana-Farber Cancer Institute & Broad Institute of MIT and Harvard to identify and validate new drug targets for gastrointestinal cancers. Now, he develops drugs for chronic inflammation.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhD
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
Promakhos TherapeuticsA therapeutics platform for curing inflammatory disorders
TagsTherapeutics
Co-foundersKaterina Chatzi
